Abstract
Seventy five elderly depressed in-patients, ages ranging from 60 to 83 years, diagnosed as Major Depression according to DSM III were treated, under double-blind conditions, with 75 mg Amitriptyline (AMI) (26 patients), 60 mg Mianserin (MIA) (24 patients) or 150 mg Trazodone (TRZ) (25 patients) p.o. for 5 weeks. There were no differences in the clinical outcome between the three groups of patients at the end of the trial, with a significant amelioration (P<0.01) at the Hamilton Rating Scale for Depression and Geriatric Depression Scale. TRZ showed a significantly lower incidence of side effects compared to MIA and AMI. Atypical antidepressants, including TRZ, seem more suitable for treating elderly depression than the first generation antidepressants on the basis of risk/benefit ratio considerations.
Similar content being viewed by others
References
Altamura AC (1987) Anxious-depressive syndromes in the elderly: assessment, clinical course and treatment. In: Racagni G, Smeraldi E (eds) Anxious depression: assessment and treatment. Raven Press, New York, pp 209–216
Altamura AC, Melorio T, Invernizzi G, Gomeni R (1982) Influence of age on mianserin pharmacokinetics. Psychopharmacology 78:380–382
Altamura AC, Melorio T, Invernizzi G, Colacurcio F, Gomeni R (1983) Age related differences in kinetics and side-effects of viloxazine in man and their clinical implications. Psychopharmacology 81:281–285
Altamura AC, Mauri MC, Guercetti G (1986) Age, therapeutic “milieu” and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels. Prog Neuropsychopharmacol Biol Psychiatry 10:67–75
Bayer AJ, Pathy MSJ, Ankier SI (1983) Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br J Clin Pharmacol 16:371–376
Brink TL, Yesavage JA, Lum O, Heersema PH, Adey M, Rose TL (1982) Screening tests for geriatric depression. Clin Gerontol 1(1)37–43
Burns M, Moskowitz H, Jaffe J (1986) A comparison of the effects of trazodone and amitriptyline on skills performance by geriatric subjects. J Clin Psychiatry 47, 5:252–256
Cazzullo CL, Altamura AC (1985) Bioavailability of some atypical antidepressants and therapeutic management of late life depressive states. Integr Psychiatry 3, 50 S–56 S
Fassler RB, Gaviria M (1978) Depression in old age. J Am Geriatr Soc 26:471–475
Frederich CT (1978) Current trends in suicidal behaviour in the United States. Am J Psychother 32:172–200
Gershon S (1984) Comparative side-effect profiles of trazodone and imipramine: special reference to a geriatric population. Psychopathology 17(2):39–50
Gottfries CG (1981) Treatment of depression in the elderly. General clinical considerations. Acta Psychiatr Scand 290 (S 63):401–409
Gram LF, Reisby N, Bech P, Nagy A, Christiansen J (1978) Factors influencing pharmacokinetics and clinical effects of tricyclic antidepressants. In: Garattini S (ed) Depressive disorders. Schattauer, Stuttgart New York, pp 337–346
Grimmson A, Idanpaan-Heikkila J, Lunde PK, Olafsson O, Westerhol MM (1977) Ferbrukninger aw psykofarmaka i Finland, Island Norge, och Sverige. Nord Med 92:49–54
Guy W (1976) ECDEU assessment manual for psychopharmacology. DHEW Publication No. 76-338, Washington, D.C.
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Montgomery SA (1982) Treatment of depression in old age. In: Wheatley D (ed) Psychopharmacology of old age. University Press, Oxford, pp 165–172
Murphy E (1983) The prognosis of depression in old age. Br J Psychiatry 142:111–119
Robinson DS (1983) Aging and neuropsychopharmacology. In: Yetiv JZ, Bianchine JR (eds) Recent advances in clinical therapeutics. Grune & Stratton, New York, pp 127–157
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Altamura, A.C., Mauri, M.C., Colacurcio, F. et al. Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin. Psychopharmacology 95, S34–S36 (1988). https://doi.org/10.1007/BF00172628
Issue Date:
DOI: https://doi.org/10.1007/BF00172628